Cargando…
What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
The process of tumorigenesis leaves a series of indelible genetic changes in tumor cells, that when expressed, have the potential to be tumor-specific immune targets. Neoantigen vaccines that capitalize on this potential immunogenicity have shown efficacy in preclinical models and have now entered c...
Autores principales: | Redwood, Alec J., Dick, Ian M., Creaney, Jenette, Robinson, Bruce W. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855878/ https://www.ncbi.nlm.nih.gov/pubmed/35186441 http://dx.doi.org/10.1080/2162402X.2022.2038403 |
Ejemplares similares
-
How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
por: Robinson, Bruce W.S., et al.
Publicado: (2022) -
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies
por: Li, Shamin, et al.
Publicado: (2021) -
Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015) -
Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2019) -
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen
por: Creaney, Jenette, et al.
Publicado: (2015)